{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:30:24Z","timestamp":1793640624877,"version":"4.5.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["QKHPTRC[2018]5772-027"],"award-info":[{"award-number":["QKHPTRC[2018]5772-027"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["QKH-JC-ZK[2021]ZD018"],"award-info":[{"award-number":["QKH-JC-ZK[2021]ZD018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160757"],"award-info":[{"award-number":["82160757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["CPG2022-00023-ICMS"],"award-info":[{"award-number":["CPG2022-00023-ICMS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["MYRG2022-00263-ICMS"],"award-info":[{"award-number":["MYRG2022-00263-ICMS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["MYRG2020-00183-ICMS"],"award-info":[{"award-number":["MYRG2020-00183-ICMS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cbi.2024.111224","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T02:27:02Z","timestamp":1725330422000},"page":"111224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Oxyphylla A exerts antiparkinsonian effects by ameliorating 6-OHDA-induced mitochondrial dysfunction and dyskinesia in vitro and in vivo"],"prefix":"10.1016","volume":"403","author":[{"given":"Min","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Hio-Cheng","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3232-8129","authenticated-orcid":false,"given":"Hefeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Ming-Yuen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.111224_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.cbi.2024.111224_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cbi.2024.111224_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.cbi.2024.111224_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson's disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2024.111224_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson's disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cbi.2024.111224_bib6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cbi.2024.111224_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cbi.2024.111224_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3233\/JPD-202221","article-title":"Treating Parkinson's disease with antibodies: previous studies and future directions","volume":"11","author":"Castonguay","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.cbi.2024.111224_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2201910120","article-title":"High-resolution structural information of membrane-bound \u03b1-synuclein provides insight into the MoA of the anti-Parkinson drug UCB0599","volume":"120","author":"Schwarz","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2024.111224_bib10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2024.111224_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","article-title":"Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson's disease","volume":"42","author":"Nguyen","year":"2019","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.cbi.2024.111224_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13578-020-00511-2","article-title":"CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?","volume":"11","author":"Tefera","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.cbi.2024.111224_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228767","article-title":"Effects of ketone bodies on brain metabolism and function in neurodegenerative diseases","volume":"21","author":"Jensen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111224_bib14","article-title":"Glycolytic metabolism, brain resilience, and Alzheimer's disease","volume":"15","author":"Zhang","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cbi.2024.111224_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fnins.2019.00629","article-title":"Altered insulin signaling in Alzheimer's disease brain - special emphasis on PI3K-Akt pathway","volume":"13","author":"Gabbouj","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cbi.2024.111224_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuint.2014.04.016","article-title":"Sulfuretin inhibits 6-hydroxydopamine-induced neuronal cell death via reactive oxygen species-dependent mechanisms in human neuroblastoma SH-SY5Y cells","volume":"74","author":"Kwon","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cbi.2024.111224_bib17","first-page":"11","article-title":"Covering the role of PGC-1\u03b1 in the nervous system","author":"Kuczynska","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2024.111224_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2014.03.008","article-title":"Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis","volume":"340","author":"Ahn","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cbi.2024.111224_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2021.09.002","article-title":"Oxyphylla A ameliorates cognitive deficits and alleviates neuropathology via the Akt-GSK3\u03b2 and Nrf2-Keap1-HO-1 pathways in vitro and in vivo murine models of Alzheimer's disease","volume":"34","author":"Bian","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.cbi.2024.111224_bib20","doi-asserted-by":"crossref","first-page":"11170","DOI":"10.1021\/acs.jafc.0c04031","article-title":"Determination of oxyphylla A enantiomers in the fruits of Alpinia oxyphylla by a chiral high-performance liquid chromatography-multiple reaction monitoring-mass spectrometry method and comparison of their in vivo biological activities","volume":"68","author":"Chen","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.cbi.2024.111224_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116745","article-title":"Antagonizing pathological \u03b1-synuclein-mediated neurodegeneration by J24335 via the activation of immunoproteasome","volume":"480","author":"Pan","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111224_bib22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.14336\/AD.2019.0612","article-title":"Oxyphylla A promotes degradation of \u03b1-synuclein for neuroprotection via activation of immunoproteasome","volume":"11","author":"Zhou","year":"2020","journal-title":"Aging Dis"},{"key":"10.1016\/j.cbi.2024.111224_bib23","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s13311-019-00759-8","article-title":"Tetramethylpyrazine analogue T-006 promotes the clearance of alpha-synuclein by enhancing proteasome activity in Parkinson's disease models","volume":"16","author":"Zhou","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.cbi.2024.111224_bib24","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s12640-021-00376-4","article-title":"Pinocembrin-7-Methylether protects SH-SY5Y cells against 6-hydroxydopamine-induced neurotoxicity via modulating Nrf2 induction through AKT and ERK pathways","volume":"39","author":"Zou","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.cbi.2024.111224_bib25","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1021\/acs.jproteome.6b00152","article-title":"Discovery, synthesis, and functional characterization of a novel neuroprotective natural product from the fruit of Alpinia oxyphylla for use in Parkinson's disease through LC\/MS-Based multivariate data analysis-guided fractionation","volume":"15","author":"Li","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cbi.2024.111224_bib26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4103\/1673-5374.266918","article-title":"Protective effects of organic extracts of Alpinia oxyphylla against hydrogen peroxide-induced cytotoxicity in PC12 cells","volume":"15","author":"Duan","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.cbi.2024.111224_bib27","first-page":"3052","article-title":"[Mechanism of volatile oil from Alpinia oxyphylla in treating Alzheimer's disease based on GC-MS and network pharmacology","volume":"46","author":"Li","year":"2021","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"10.1016\/j.cbi.2024.111224_bib28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jep.2018.02.015","article-title":"Protective effects of Alpinae Oxyphyllae Fructus extracts on lipopolysaccharide-induced animal model of Alzheimer's disease","volume":"217","author":"Wang","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cbi.2024.111224_bib29","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.neurobiolaging.2015.06.022","article-title":"Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson's disease","volume":"36","author":"Choi","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cbi.2024.111224_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2016.10.019","article-title":"Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K\/AKT\/Bcl-2 and Nrf2\/HO-1 pathways","volume":"11","author":"Zhang","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.cbi.2024.111224_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuro.2013.03.004","article-title":"Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease","volume":"36","author":"Morroni","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2024.111224_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/NEN.0000000000000095","article-title":"Rho kinase inhibition by fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease","volume":"73","author":"Tatenhorst","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cbi.2024.111224_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.alcohol.2018.10.010","article-title":"Alcohol hangover effects on brain cortex non-synaptic mitochondria and synaptosomes bioenergetics","volume":"77","author":"Karadayian","year":"2019","journal-title":"Alcohol"},{"key":"10.1016\/j.cbi.2024.111224_bib34","doi-asserted-by":"crossref","first-page":"e963","DOI":"10.1038\/tp.2016.230","article-title":"Clozapine modifies the differentiation program of human adipocytes inducing browning","volume":"6","author":"Krist\u00f3f","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.cbi.2024.111224_bib35","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1016\/j.molcel.2021.09.001","article-title":"KARATE: PKA-induced KRAS4B-RHOA-mTORC2 supercomplex phosphorylates AKT in insulin signaling and glucose homeostasis","volume":"81","author":"Senoo","year":"2021","journal-title":"Mol. Cell."},{"key":"10.1016\/j.cbi.2024.111224_bib36","doi-asserted-by":"crossref","first-page":"27160","DOI":"10.1074\/jbc.M116.763235","article-title":"G protein-coupled receptors (GPCRs) that signal via protein kinase A (PKA) cross-talk at insulin receptor substrate 1 (IRS1) to activate the phosphatidylinositol 3-kinase (PI3K)\/AKT pathway","volume":"291","author":"Law","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2024.111224_bib37","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1096\/fj.201802351R","article-title":"M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1 via a signaling pathway linking cAMP-PKA and PI3K-Akt","volume":"33","author":"Zhao","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.cbi.2024.111224_bib38","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1038\/s41598-019-46359-6","article-title":"Mitochondrial Akt signaling modulated reprogramming of somatic cells","volume":"9","author":"Chen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2024.111224_bib39","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.7150\/thno.43577","article-title":"Exercise protects proliferative muscle satellite cells against exhaustion via the Igfbp7-Akt-mTOR axis","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cbi.2024.111224_bib40","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1159\/000485580","article-title":"The key roles of GSK-3\u03b2 in regulating mitochondrial activity","volume":"44","author":"Yang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2024.111224_bib41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","article-title":"Glycogen synthase kinase-3 beta (GSK-3\u03b2) signaling: implications for Parkinson's disease","volume":"97","author":"Golpich","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2024.111224_bib42","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fphys.2015.00332","article-title":"Protein kinase A governs oxidative phosphorylation kinetics and oxidant emitting potential at complex I","volume":"6","author":"Lark","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cbi.2024.111224_bib43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/cns.13141","article-title":"Phosphoregulation on mitochondria: integration of cell and organelle responses","volume":"25","author":"Lucero","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cbi.2024.111224_bib44","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118818119","article-title":"Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model","volume":"119","author":"Sun","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2024.111224_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/biom12050661","article-title":"Hyperbaric oxygen therapy improves Parkinson's disease by promoting mitochondrial biogenesis via the SIRT-1\/PGC-1\u03b1 pathway","volume":"12","author":"Hsu","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.cbi.2024.111224_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175300","article-title":"NLRP3 inflammasomes: a potential target to improve mitochondrial biogenesis in Parkinson's disease","volume":"934","author":"Khot","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111224_bib47","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1523\/JNEUROSCI.1419-21.2022","article-title":"CREB inactivation by HDAC1\/PP1\u03b3 contributes to dopaminergic neurodegeneration in Parkinson's disease","volume":"42","author":"Xu","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2024.111224_bib48","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3892\/etm.2015.2958","article-title":"Rolipram stimulates angiogenesis and attenuates neuronal apoptosis through the cAMP\/cAMP-responsive element binding protein pathway following ischemic stroke in rats","volume":"11","author":"Hu","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cbi.2024.111224_bib49","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s43440-023-00526-9","article-title":"Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration","volume":"75","author":"Khakha","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.cbi.2024.111224_bib50","doi-asserted-by":"crossref","first-page":"12121","DOI":"10.1039\/D2FO02854A","article-title":"Neuroprotective effects of a new triterpenoid from edible mushroom on oxidative stress and apoptosis through the BDNF\/TrkB\/ERK\/CREB and Nrf2 signaling pathway in vitro and in vivo","volume":"13","author":"Kou","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.cbi.2024.111224_bib51","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/bph.14983","article-title":"Roflupram exerts neuroprotection via activation of CREB\/PGC-1\u03b1 signalling in experimental models of Parkinson's disease","volume":"177","author":"Zhong","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111224_bib52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1326-8-6","article-title":"Mitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewy body expression","volume":"8","author":"Cronin-Furman","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cbi.2024.111224_bib53","doi-asserted-by":"crossref","first-page":"14897","DOI":"10.18632\/aging.103551","article-title":"Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson's disease models through activating the MEF2-PGC1\u03b1 and BDNF\/CREB pathways","volume":"12","author":"Chen","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cbi.2024.111224_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neures.2020.09.001","article-title":"Parkin-linked Parkinson's disease: from clinical insights to pathogenic mechanisms and novel therapeutic approaches","volume":"159","author":"Wasner","year":"2020","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.cbi.2024.111224_bib55","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1073\/pnas.0605208103","article-title":"Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2024.111224_bib56","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fphys.2017.00544","article-title":"\u03b2-Catenin knockdown affects mitochondrial biogenesis and lipid metabolism in breast cancer cells","volume":"8","author":"Vergara","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cbi.2024.111224_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2024.111224_bib58","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210289","article-title":"Molecular mechanisms of developmental pathways in neurological disorders: a pharmacological and therapeutic review","volume":"12","author":"Jha","year":"2022","journal-title":"Open Biol"},{"key":"10.1016\/j.cbi.2024.111224_bib59","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac047","article-title":"Jumonji domain-containing protein-3 (JMJD3\/Kdm6b) is critical for normal ovarian function and female fertility","volume":"163","author":"Roy","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2024.111224_bib60","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1186\/s12885-023-11480-3","article-title":"MAPK1 promotes the metastasis and invasion of gastric cancer as a bidirectional transcription factor","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cbi.2024.111224_bib61","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4161\/auto.6458","article-title":"Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease","volume":"4","author":"Dagda","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2024.111224_bib62","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1038\/cddis.2012.46","article-title":"Impaired mitochondrial biogenesis contributes to depletion of functional mitochondria in chronic MPP+ toxicity: dual roles for ERK1\/2","volume":"3","author":"Zhu","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2024.111224_bib63","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrn2665","article-title":"Mitochondrial membrane permeabilization in neuronal injury","volume":"10","author":"Galluzzi","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cbi.2024.111224_bib64","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/mds.23604","article-title":"Variants in estrogen-related genes and risk of Parkinson's disease","volume":"26","author":"Chung","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cbi.2024.111224_bib65","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/ars.2022.0001","article-title":"Restoration of c-src\/fyn proteins rescues mitochondrial dysfunction in huntington's disease","volume":"38","author":"F\u00e3o","year":"2023","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.cbi.2024.111224_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072464","article-title":"Historical perspective: models of Parkinson's disease","volume":"21","author":"Chia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111224_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","article-title":"The ongoing pursuit of neuroprotective therapies in Parkinson disease","volume":"11","author":"Athauda","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cbi.2024.111224_bib68","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/1673-5374.380878","article-title":"Single-neuron neurodegeneration as a degenerative model for Parkinson's disease","volume":"19","author":"Huenchuguala","year":"2024","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.cbi.2024.111224_bib69","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/mds.25175","article-title":"Design innovations and baseline findings in a long-term Parkinson's trial: the national Institute of neurological disorders and stroke exploratory trials in Parkinson's disease long-term study-1","volume":"27","author":"Elm","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cbi.2024.111224_bib70","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease","volume":"25","author":"Snow","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cbi.2024.111224_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/biom14060673","article-title":"Targets to search for new pharmacological treatment in idiopathic Parkinson's disease according to the single-neuron degeneration model","volume":"14","author":"Huenchuguala","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.cbi.2024.111224_bib72","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1007\/s00018-016-2182-5","article-title":"Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson's disease","volume":"73","author":"Herrera","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cbi.2024.111224_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12030673","article-title":"A preclinical model for Parkinson's disease based on transcriptional gene activation via KEAP1\/NRF2 to develop new antioxidant therapies","volume":"12","author":"Segura-Aguilar","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.cbi.2024.111224_bib74","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2024.111224_bib75","article-title":"Role of Nrf2 in Parkinson's disease: toward new perspectives","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724003703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724003703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:50:41Z","timestamp":1762113041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724003703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":75,"alternative-id":["S0009279724003703"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111224","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxyphylla A exerts antiparkinsonian effects by ameliorating 6-OHDA-induced mitochondrial dysfunction and dyskinesia in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111224"}}